By Bryan Koenig ( August 28, 2023, 8:23 PM EDT) -- The Federal Trade Commission appears to be mulling a deal resolving its challenge to Amgen's planned $27.8 billion purchase of Horizon Therapeutics, publicly disclosing that the agency had pulled the case from its in-house docket — but not the federal docket — for "proper resolution."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.